Company intelligence / Profile preview

Royer Biomedical

Frederick, Maryland, United Statesroyerbiomedical.com ↗

Ownership: Private
Development stage: Commercial

Overview

Royer Biomedical has developed proprietary synthetic polymer platforms capable of delivering a range of pharmaceutical compounds with controlled elution rates. The company holds numerous US and international patents on these technologies. Their focus includes applications in diabetes, orthopedics, cancer therapy, infection control, and biofilm management. No published late-stage clinical results are available as of now.

Therapeutic areas: OncologyEndocrinologyInfectious Diseases
Modalities: Localized drug delivery systems (polymer matrices)Hydrogel and calcium-based matrices for pharmaceuticalsNovel formulations of existing drugs (anti-infective, anti-neoplastic, analgesic)
Industry: Biotech

Drug pipeline

2 assets

AppliGel-G

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Royer Biomedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Royer Biomedical.

Explore the full profile